SUSAN RANDALL-MANTELLA: Open Payments
NPI 1457314650 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 5 payments from 5 companies in 2025. Trend: 2023 $107 · 2024 $97 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $14 |
Products named: REXULTI, TRELEGY ELLIPTA, VOQUEZNA, PAXLOVID, Rybelsus.
Industry payments across NY — which companies pay providers there.
